What's happening
This bill removes THC dose limits and expands the list of medical conditions eligible for medical marijuana in New York.
Why it matters
Eliminates the cap on THC per dose. , allowing healthcare providers more flexibility to prescribe medical marijuana in quantities tailored to individual patient needs, which may benefit those who require higher doses for effective symptom management.
Broadens the list of qualifying medical conditions. , explicitly adding Alzheimer’s disease, traumatic brain injury, dystonia, muscular dystrophy, wasting syndrome, post-traumatic stress disorder (PTSD), rheumatoid arthritis, and lupus—potentially increasing access for patients previously excluded.
Removes delays for new conditions to be added. , by striking previous language that required the Department of Health to wait and review certain conditions; this makes it easier and faster for patients with newly recognized conditions to obtain medical marijuana.
May impact medical guidance and oversight. , shifting more responsibility to practitioners to determine appropriate dosing and appropriate conditions, which could affect how medical marijuana is recommended and monitored in New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Expand Medical Marijuana Access
Plain English, a few words. Used as the page title.
Sponsors
32 Co-sponsors
- Donna Lupardo
- Jeffrey Dinowitz
- Amy Paulin
- Andrew Hevesi
- Michael Blake
- Anthony Brindisi
- Vivian Cook
- Felix Ortiz
- Addie Jenne
- Luis R. Sepúlveda
- Jo Anne Simon
- Frank Skartados
- James Skoufis
- Kenneth Zebrowski
- John T. McDonald III
- Walter T. Mosley
- Pamela J. Hunter
- Albert A. Stirpe
- Thomas Abinanti
- Steven Englebright
- Steven Cymbrowitz
- Joseph Lentol
- Yuh-Line Niou
- Robert C. Carroll
- Marcos Crespo
- Linda Rosenthal
- Anthony D'Urso
- Phil Steck
- Barbara Lifton
- Sandy Galef
- Melissa Miller
- David Weprin
3 Multi-sponsors
History
- Starred on calendar
- Ordered to third reading cal.323
- Advanced to third reading cal.208
- Reported
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Expand Medical Marijuana Access
In Senate Committee · Health · Sponsor Diane J. Savino
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4276
2017-2018 Regular Sessions
IN ASSEMBLY
February 2, 2017
Introduced by M. of A. GOTTFRIED, LUPARDO, DINOWITZ, PAULIN, HEVESI, BLAKE, BRINDISI, COOK, ORTIZ, JENNE, SEPULVEDA, SIMON, SKARTADOS, SKOUFIS, ZEBROWSKI, McDONALD -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to dosing limitations and medical conditions permitting the medical use of marihuana
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 15 of section 3360 of the public health law, as added by chapter 90 of the laws of 2014, is amended to read as follows:
15. "Individual dose" means a single measure of raw medical marihuana or non-infused concentrates to be determined and clearly identified by a patient's practitioner for the patient's specific certified condition. [For ingestible or sub-lingual medical marihuana products, no individual dose may contain more than ten milligrams of tetrahydrocannabinol.]
§ 2. Subdivision 7 of section 3360 of the public health law, as added by chapter 90 of the laws of 2014, is amended to read as follows:
7. [(a)] "Serious condition" means:
(i) having one of the following severe debilitating or life-threatening conditions: cancer, positive status for human immunodeficiency virus or acquired immune deficiency syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, dystonia, Parkinson's disease, multiple sclerosis, muscular dystrophy, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, wasting syndrome, post traumatic stress disorder, rheumatoid arthritis, lupus, inflammatory bowel disease, neuropathies, Huntington's disease, or as added by the commissioner; [and] or
(ii) any of the following conditions where it is clinically associated with, or a complication of, a condition under this paragraph or its treatment: cachexia or wasting syndrome; severe or chronic pain; severe
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02522-01-7
A. 4276 2
nausea; seizures; severe or persistent muscle spasms; or such conditions as are added by the commissioner.
[(b) No later than eighteen months from the effective date of this section, the commissioner shall determine whether to add the following serious conditions: Alzheimer's, muscular dystrophy, dystonia, posttraumatic stress disorder and rheumatoid arthritis.]
§ 3. This act shall take effect immediately; provided that the amendments to title 5-a of article 33 of the public health law made by this act shall not affect the repeal of such title and shall be deemed repealed therewith.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.